A Simple, Safe Pathway from Clearance to Market and Beyond.

Get to market in months, not years, without hiring a quality team, building supplier infrastructure, or drowning in FDA compliance paperwork.

Regulatory-Safe Partnership Model

QMSR Transition Ready​

Aligned with ISO 13485:2016 and FDA Quality Management System Regulation (21 CFR 820)

Capital-Efficient Operations

Reduce fixed overhead and avoid building internal quality and operations teams

What we do

Clearway Medical is the operational backbone for post-510(k) medical device companies. We run your quality systems, supplier network, and post-market compliance so you can focus on sales, growth, and exit strategy.

We provide the turnkey quality, supply chain, and regulatory infrastructure you need to get to market in 3-4 months without hiring Quality teams or drowning in paperwork.

In Short: You lead the strategy. We run the regulated execution layer

The Post-Clearance Challenge

FDA clearance is a milestone—not the finish line. The real work begins when quality systems, supplier networks, and post-market processes must operate reliably at commercial scale.

Clearway Medical builds the operating platform behind your product—so you can focus on innovation, market expansion, and long-term value creation.

Who We Partner With

  • Post-510(k) startups launching their first commercial product
  • Established manufacturers expanding into new product lines
  • Strategic and innovation teams running pilot programs
  • Companies modernizing quality systems for QMSR and ISO 13485 alignment

Clearway Medical serves as the operational backbone for organizations that want to scale, innovate, and enter new markets without expanding internal headcount.

Experience & Credibility

Proven Across Device Categories and Regulatory Environments

Our team brings hands-on experience supporting medical-device organizations through commercialization, audits, and regulatory interactions across multiple clinical and technical domains.

Experience Highlights:

  • Orthopedic, SAMD, and diagnostic devices
  • Class I, II, and select Class III programs
  • U.S. FDA inspections and ISO 13485 certification audits
  • Multi-supplier and international manufacturing networks
  • Early-stage commercialization and enterprise portfolio expansion

What Clients Rely On

  • Practical, operator-led quality systems not theoretical frameworks
  • Clear governance models that stand up in audits and diligence
  • Scalable supplier and post-market infrastructures

Program Experience

XXX commercialization and quality programs supported

Regulatory Exposure

FDA inspections and ISO 13485
certification audits

Supplier Network

Multi-site and international
manufacturing partners

Operational Scope

Post-market surveillance, CAPA, and
QMSR transition programs Client
references and case examples are
available upon request.

Ready to Simplify Your Path to Market?

Scroll to Top